XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 6.61%-567.06M | 1.91%-328.58M | -12.29%720.86M | -7.07%300.6M | 6.54%1.36B | -32.34%-607.18M | -4.14%-334.99M | 1.65%821.84M | -25.71%323.46M | -0.61%1.28B |
Net income from continuing operations | -28.28%-243.42M | -5.56%-172.58M | 7.52%595.32M | -14.71%257.82M | 7.35%690.74M | 15.13%-189.76M | 2.93%-163.48M | 0.00%553.7M | 35.73%302.27M | -4.42%643.43M |
Depreciation and amortization | -3.03%29.2M | -4.61%28.83M | -6.68%121.78M | -3.33%30.78M | -5.08%30.67M | -8.00%30.11M | -10.11%30.23M | -8.21%130.5M | -8.28%31.84M | -10.53%32.31M |
Deferred tax | -1,020.12%-20.54M | 150.34%19.01M | -182.58%-40.94M | -59.71%17.28M | 34.87%-22.7M | -90.93%2.23M | -323.18%-37.76M | 192.93%49.58M | 35.01%42.89M | 65.77%-34.85M |
Change In working capital | 24.77%-361.22M | -23.73%-213.59M | -1,723.06%-72.15M | 42.07%-35.46M | 3.29%616.11M | -50.86%-480.17M | 18.77%-172.62M | -93.16%4.45M | -149.00%-61.21M | -4.92%596.47M |
-Change in receivables | 25.56%-263.38M | -79.34%1.03M | -89.35%-108.39M | 33.06%239.71M | -97.08%727K | -33.02%-353.81M | 34.55%4.98M | -51.08%-57.24M | -7.84%180.15M | 243.99%24.9M |
-Change in prepaid assets | 54.70%-6.25M | 38.15%8.84M | -3.94%-7.29M | 3.10%10.75M | -168.46%-10.64M | 54.51%-13.79M | 339.64%6.4M | -260.65%-7.01M | -28.49%10.43M | -48.87%15.55M |
-Change in payables and accrued expense | -185.23%-10.79M | 7.28%-66.02M | 93.11%-4.66M | -20.07%-227.71M | 15.79%281.59M | 44.64%12.66M | 45.19%-71.2M | -244.25%-67.63M | -33.79%-189.65M | -0.35%243.18M |
-Change in other working capital | 35.48%-80.8M | -39.58%-157.44M | -64.65%48.2M | 6.31%-58.21M | 10.10%344.44M | -307.40%-125.23M | -34.86%-112.8M | 9.54%136.33M | -209.72%-62.13M | -15.49%312.84M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 6.61%-567.06M | 1.91%-328.58M | -12.29%720.86M | -7.07%300.6M | 6.54%1.36B | -32.34%-607.18M | -4.14%-334.99M | 1.65%821.84M | -25.71%323.46M | -0.61%1.28B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -29.57%-61.1M | -10.48%-26.39M | 7.43%-93.86M | 5,771.57%5.79M | -1,201.68%-28.6M | 23.61%-47.16M | 36.05%-23.89M | -32.46%-101.39M | 98.12%-102K | 83.92%-2.2M |
Capital expenditure reported | -53.50%-30.38M | -45.05%-18.74M | 8.64%-63.68M | 24.47%-9.85M | -39.28%-21.12M | 21.88%-19.79M | 20.08%-12.92M | -12.50%-69.7M | -41.14%-13.04M | -13.63%-15.17M |
Net business purchase and sale | -9.27%-22.12M | 14.71%-5.9M | 10.13%-43.36M | 61.46%-195K | -100.49%-16.01M | 12.95%-20.24M | 58.08%-6.92M | -34.32%-48.25M | 95.16%-506K | -30.19%-7.98M |
Net other investing changes | -20.76%-8.6M | 56.65%-1.76M | -20.40%13.18M | 17.75%15.83M | -59.29%8.53M | 45.82%-7.12M | 13.54%-4.06M | -22.40%16.56M | -5.72%13.44M | 260.19%20.95M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -29.57%-61.1M | -10.48%-26.39M | 7.43%-93.86M | 5,771.57%5.79M | -1,201.68%-28.6M | 23.61%-47.16M | 36.05%-23.89M | -32.46%-101.39M | 98.12%-102K | 83.92%-2.2M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 2.34%543.05M | -45.72%-284.45M | 24.86%-564.31M | 82.15%-43.81M | -34.92%-855.95M | 41.24%530.65M | 20.94%-195.2M | 40.27%-750.99M | 55.37%-245.41M | -13.78%-634.4M |
Net issuance payments of debt | ---- | ---- | --0 | --0 | -37.93%-800M | ---- | ---- | --0 | --0 | -110.91%-580M |
Net common stock issuance | 13.32%-197.86M | -58.45%-238.38M | 33.29%-379.57M | 99.73%-551K | -41.10%-309K | -40.22%-228.27M | 25.83%-150.44M | -1.03%-568.95M | -2,462.13%-203.1M | 99.91%-219K |
Cash dividends paid | -11.53%-52.31M | -3.96%-44.65M | -1.04%-179.78M | -1.10%-44.65M | -1.58%-45.27M | -1.74%-46.9M | 0.32%-42.95M | 4.59%-177.93M | -2.61%-44.16M | 4.15%-44.57M |
Net other financing activities | -44.75%3.21M | 21.19%-1.42M | -20.70%-4.97M | -25.13%1.39M | -7.88%-10.37M | 26.56%5.81M | -88.80%-1.8M | 46.53%-4.12M | -67.36%1.86M | -61.11%-9.61M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 2.34%543.05M | -45.72%-284.45M | 24.86%-564.31M | 82.15%-43.81M | -34.92%-855.95M | 41.24%530.65M | 20.94%-195.2M | 40.27%-750.99M | 55.37%-245.41M | -13.78%-634.4M |
Net cash flow | ||||||||||
Beginning cash position | -4.05%439.02M | 5.90%1.08B | -3.37%1.02B | -13.02%812.7M | 15.76%338.22M | 6.07%457.56M | -3.37%1.02B | -33.67%1.05B | -20.62%934.35M | -36.47%292.19M |
Current changes in cash | 31.19%-85.11M | -15.40%-639.43M | 305.28%62.69M | 236.86%262.57M | -25.59%477.88M | 14.59%-123.69M | 8.56%-554.08M | 94.19%-30.54M | 165.01%77.95M | -10.23%642.25M |
Effect of exchange rate changes | -384.71%-12.39M | 188.31%3.25M | 42.06%-2.81M | -102.48%-75K | -3,688.89%-3.41M | -22.76%4.35M | 72.59%-3.68M | 40.04%-4.86M | 146.98%3.02M | -105.41%-90K |
End cash Position | 0.98%341.52M | -4.05%439.02M | 5.90%1.08B | 5.90%1.08B | -13.02%812.7M | 15.76%338.22M | 6.07%457.56M | -3.37%1.02B | -3.37%1.02B | -20.62%934.35M |
Free cash flow | 4.71%-597.44M | 0.17%-347.32M | -12.63%657.18M | -6.34%290.75M | 6.14%1.34B | -29.51%-626.97M | -2.98%-347.91M | 0.74%752.14M | -27.16%310.42M | -0.76%1.26B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |